Literature DB >> 26304704

Animal models for studying dengue pathogenesis and therapy.

Kitti Wing Ki Chan1, Satoru Watanabe2, Ranmali Kavishna3, Sylvie Alonso3, Subhash G Vasudevan4.   

Abstract

Development of a suitable animal model for dengue virus disease is critical for understanding pathogenesis and for preclinical testing of antiviral drugs and vaccines. Many laboratory animal models of dengue virus infection have been investigated, but the challenges of recapitulating the complete disease still remain. In this review, we provide a comprehensive coverage of existing models, from man to mouse, with a specific focus on recent advances in mouse models for addressing the mechanistic aspects of severe dengue in humans. This article forms part of a symposium in Antiviral Research on flavivirus drug discovery.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AG129 mice; Animal models; Antiviral therapy; Dengue; Dengue hemorrhagic fever

Mesh:

Year:  2015        PMID: 26304704     DOI: 10.1016/j.antiviral.2015.08.013

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  36 in total

Review 1.  Animal Models of Zika Virus.

Authors:  Michael P Bradley; Claude M Nagamine
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

Review 2.  Humanized mouse models to study human cell-mediated and humoral responses to dengue virus.

Authors:  Anuja Mathew
Journal:  Curr Opin Virol       Date:  2017-08-09       Impact factor: 7.090

Review 3.  Mouse models of dengue virus infection for vaccine testing.

Authors:  Vanessa V Sarathy; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

4.  A lethal model of disseminated dengue virus type 1 infection in AG129 mice.

Authors:  Gregg N Milligan; Vanessa V Sarathy; Mellodee M White; M Banks Greenberg; Gerald A Campbell; Richard B Pyles; Alan D T Barrett; Nigel Bourne
Journal:  J Gen Virol       Date:  2017-09-27       Impact factor: 3.891

5.  A fluorescence-activatable reporter of flavivirus NS2B-NS3 protease activity enables live imaging of infection in single cells and viral plaques.

Authors:  Jorge L Arias-Arias; Derek J MacPherson; Maureen E Hill; Jeanne A Hardy; Rodrigo Mora-Rodríguez
Journal:  J Biol Chem       Date:  2020-01-09       Impact factor: 5.157

6.  Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008.

Authors:  Gregg N Milligan; Mellodee White; Diana Zavala; Richard B Pyles; Vanessa V Sarathy; Alan D T Barrett; Nigel Bourne
Journal:  Antiviral Res       Date:  2018-04-14       Impact factor: 5.970

7.  18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response.

Authors:  Ann-Marie Chacko; Satoru Watanabe; Keira J Herr; Shirin Kalimuddin; Jing Yang Tham; Joanne Ong; Marie Reolo; Raymond Mf Serrano; Yin Bun Cheung; Jenny Gh Low; Subhash G Vasudevan
Journal:  JCI Insight       Date:  2017-05-04

8.  Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment.

Authors:  Szu-Yuan Pu; Fei Xiao; Stanford Schor; Elena Bekerman; Fabio Zanini; Rina Barouch-Bentov; Claude M Nagamine; Shirit Einav
Journal:  Antiviral Res       Date:  2018-05-16       Impact factor: 5.970

Review 9.  The use of humanized mice for studies of viral pathogenesis and immunity.

Authors:  Florian Douam; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2018-03-28       Impact factor: 7.090

10.  Evaluation of Aedes aegypti, Aedes albopictus, and Culex quinquefasciatus Mosquitoes Competence to Oropouche virus Infection.

Authors:  Silvana F de Mendonça; Marcele N Rocha; Flávia V Ferreira; Thiago H J F Leite; Siad C G Amadou; Pedro H F Sucupira; João T Marques; Alvaro G A Ferreira; Luciano A Moreira
Journal:  Viruses       Date:  2021-04-25       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.